Your email has been successfully added to our mailing list.

×
0 0 0 0 0 -0.0166666666666667 -0.00666666666666664 0.0133333333333334
Stock impact report

Arcus stock jumps on Bloomberg News report that Gilead may take a stake [MarketWatch]

Arcus Biosciences, Inc. (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report
Company Research Source: MarketWatch
Shares of Arcus Biosciences Inc. soared 87% in trading on Thursday after people familiar with the matter told Bloomberg News that Gilead Sciences Inc. was in talks to buy a stake in the company. Arcus has several experimental cancer drugs in Phase 1 and 2 clinical trials. Gilead's most recent deal was also an oncology-focused, preclinical company; in early March, it said it would pay $4.9 billion to acquire Forty Seven Inc. to build out its oncology portfolio. Arcus's stock is up 191.7% year-to-date; the S&P 500 is down 13.8%. Show less Read more
Impact Snapshot
Event Time:
RCUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RCUS alerts
Opt-in for
RCUS alerts

from News Quantified
Opt-in for
RCUS alerts

from News Quantified